Trials / Unknown
UnknownNCT03678649
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
A Prospective Randomized Controlled Clinical Trial of Capecitabine Treatment in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck After Radiotherapy: Phase II Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This prospective randomized controlled clinical Trial will be performed in patients with locally advanced squamous cell carcinoma of the head and neck. The objectives of the trial are to compare the efficacy and safety of Capecitabine treatment with placebo as adjuvant therapy to patients who have received radiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capecitabine | 1000-1250 mg/m2 orally twice daily for 14 days followed by a 1-week rest period, given as 3- week cycles for a total of 6 cycles . |
Timeline
- Start date
- 2018-09-10
- Primary completion
- 2020-12-30
- Completion
- 2023-12-30
- First posted
- 2018-09-19
- Last updated
- 2018-09-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03678649. Inclusion in this directory is not an endorsement.